Callan Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $385K | Buy |
3,436
+377
| +12% | +$42.2K | 0.03% | 242 |
|
|
2024
Q4 | $283K | Buy |
3,059
+42
| +1% | +$3.88K | 0.02% | 265 |
|
|
2024
Q3 | $253K | Sell |
3,017
-2,282
| -43% | -$191K | 0.02% | 291 |
|
|
2024
Q2 | $364K | Buy |
5,299
+608
| +13% | +$41.7K | 0.03% | 206 |
|
|
2024
Q1 | $344K | Buy |
4,691
+62
| +1% | +$4.54K | 0.03% | 186 |
|
|
2023
Q4 | $375K | Buy |
+4,629
| New | +$375K | 0.04% | 151 |
|
|
2015
Q1 | – | Sell |
-2,948
| Closed | -$278K | – | 71 |
|
|
2014
Q4 | $278K | Buy |
+2,948
| New | +$278K | 0.06% | 66 |
|